Skip to main content
NCBI home page
PLOS One logoLink to PLOS One
. 2020 Mar 11;15(3):e0230505. doi: 10.1371/journal.pone.0230505

Correction: Five-year outcomes of photodynamic therapy combined with intravitreal injection of ranibizumab or aflibercept for polypoidal choroidal vasculopathy

Wataru Kikushima, Atsushi Sugiyama, Seigo Yoneyama, Mio Matsubara, Yoshiko Fukuda, Ravi Parikh, Yoichi Sakurada
PMCID: PMC7065785  PMID: 32160267

The first author’s first and last name appear in the incorrect order. The correct name is: Wataru Kikushima. The correct citation is: Kikushima W, Sugiyama A, Yoneyama S, Matsubara M, Fukuda Y, Parikh R, et al. (2020) Five-year outcomes of photodynamic therapy combined with intravitreal injection of ranibizumab or aflibercept for polypoidal choroidal vasculopathy. PLoS ONE 15(2): e0229231. https://doi.org/10.1371/journal.pone.0229231

Reference

  • 1.Wataru K, Sugiyama A, Yoneyama S, Matsubara M, Fukuda Y, Parikh R, et al. (2020) Five-year outcomes of photodynamic therapy combined with intravitreal injection of ranibizumab or aflibercept for polypoidal choroidal vasculopathy. PLoS ONE 15(2): e0229231 10.1371/journal.pone.0229231 [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from PLoS ONE are provided here courtesy of PLOS

RESOURCES